Bickford Pharmaceuticals

Effective and Efficient Treatments for the Avian Species

About Us

  • Seeking FDA Approval

    Bickford Pharmaceuticals is currently seeking FDA drug approval for a proposed avian autologous drug product.

  • Extensive Experience

    Bickford Pharmaceuticals’ lead product developer has extensive experience and results on the isolation, culture expansion, and guided differentiation (in particular, towards bone and cartilage lineage) of bone marrow MSCs.

  • Source of Stem Cells

    MSCs are readily obtained from at least 3 major tissue sources – bone marrow, adipose (fat), and muscle.

Our Technology

We plan to create a solution with bone marrow-derived avian stem cells for the avian species.

Contact us.

info@bickfordpharma.com

+1 603-254-7119